MedQuist, a Mount Laurel, N.J.-based company specializing in clinical workflow solutions and electronic health records, has appointed Brian O'Donoghue and Mark Schwarz to its board if directors, according to a company news release.
O'Donoghue, 44, is a founder and managing member of the private-investment management firm Arklow Capital, and Schwarz, 47, is general partner of the hedge-fund management group Newcastle Partners. The appointments fill two of the three independent-director positions left vacant following board member resignations in November. -- by Shawn Rhea / HITS staff writer
Making news? Send your personal and personnel healthcare IT news to [email protected]. Please attach a color photo of your HITS News Maker with your submission.